Value Bridge — NYC HEALTH + HOSPITAL / SOUTH BROOKL
Current $-97M → Target $-84M (+$13.0M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-97.1M
Current EBITDA
$-84.1M
Target EBITDA
+$13.0M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$2.9M
Payer Mix Optimization
$7.1M
Cost to Collect Reduction
$2.4M
Clean Claim Improvement
$1.8M
Volume & Rate Growth
$11.8M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-97M to $-84M. The highest-impact lever is Volume & Rate Growth at $4.7M probability-weighted.
IC talking point: "We see $13M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $143M in equity value creation."